JPMorgan cuts target for Xylem stock from USD 137 to USD 118

Published on 10/20/2026 at 14:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JPMorgan cut its target from USD 137 to USD 118. Xylem stock costs EUR 92.70 on October 20, 2026, 0.10 percent below the Xetra close.

Analyst revisions precede quarterly results

JPMorgan reduced the target from USD 137 to USD 118 on October 19, 2026.
Second-quarter 2026 revenue was USD 2.34 billion and adjusted EPS was USD 1.46.
Xylem stock trades at EUR 92.70 at 2:11 p.m. CEST at Lang & Schwarz on October 20, 2026, 0.10 percent below the Xetra close of October 19, 2026.
The next report is scheduled for October 27, 2026, before market open.

Geometrisches Bauhaus-Poster in Blautönen mit Schriftzug WATER und Wellenmuster — Geometrisches Bauhaus-Poster mit dem Wort WATER symbolisiert den Sektor von Xylem Inc. (US98419M1009) treffend, Illustration mit AI erstellt.

Xylem Inc. (US98419M1009) stock was at EUR 92.70 at Lang & Schwarz on October 20, 2026 at 2:11 p.m. CEST, 0.10 percent below the Xetra close of October 19, 2026 at EUR 92.79. According to MarketScreener on October 19, 2026, JPMorgan cut its Xylem target from USD 137 to USD 118 while keeping a Neutral rating.

Three analyst signals in October

The latest revision followed a broader reset in valuation assumptions. Investing.com reported on October 19, 2026 that Stifel reduced its target from USD 160 to USD 141 while retaining a Buy rating. Borse Express reported on October 16, 2026 that Mizuho lowered its target from USD 130 to USD 110 and kept a Neutral rating.

The chronology starts with Xylem's second-quarter report on July 28, 2026, when adjusted earnings per share reached USD 1.46 against USD 1.34 consensus. Mizuho's October 15, 2026 revision moved its target to USD 110 from USD 130. JPMorgan's October 19, 2026 action then set the latest target at USD 118 from USD 137.

What do the targets imply?

The USD 118 JPMorgan target stands 13.98 percent above the USD 103.53 last price on the NYSE at the October 19, 2026 session close. That gap is smaller than the target implied by Stifel's USD 141 view, while both firms retained their existing ratings.

Dates for the next test

MarketBeat lists October 27, 2026 as the next reporting date, before the market opens, with a conference call scheduled for 9:00 a.m. ET. The consensus calls for third-quarter 2026 adjusted earnings per share of USD 1.45 and revenue of USD 2.28 billion.

Zacks says Xylem's second-quarter 2026 adjusted earnings per share of USD 1.46 exceeded the USD 1.34 consensus by USD 0.12, an 8.96 percent surprise. The upcoming report will therefore test whether earnings strength can offset the analysts' lower valuation assumptions.

Stock holds near its yearly low

The primary NYSE quote stood at USD 103.53 on October 19, 2026, against a 52-week range of USD 98.58 to USD 154.27. Xylem's market capitalization was USD 24.2 billion on that date, leaving the company only 5.02 percent above the lower end of its yearly range.

The further course of trading is shown by the continuously updated real-time quote of Xylem stock.